Sectoral Asset Management

Sectoral Asset Management

Sectoral Asset Management

Follow us
the home of AI info

Unum Therapeutics Inc. (UMRX)'s Financial Results Comparing With Minerva Neurosciences Inc ...

PE HUB

VC-backed Aprea Therapeutics sets IPO pricing terms

€50,000,000 Venture capital (Series C)
FinSMEs , PE HUB

Aprea Therapeutics Closes €50M Series C Financing

$20,000,000 Venture capital (Series B)
FinSMEs

BioClin Therapeutics Raises $20M; Completes $50M Series B Financing

Funding Health
$69,200,000 IPO
PE HUB

VC-backed Unum Therapeutics rolls out IPO

Stock markets Health
Xconomy

Unum Therapeutics IPO Raises $69M to Test Universal Cell Therapies

Health Stock markets
$23,000,000 Venture capital (Series B)
FinSMEs

Simplify Medical Closes $23.25M in Second Tranche of Series B Financing Totaling $44.25M

Health Funding
$60,000,000 Venture capital (Series E)
bizjournals , businesswire

https://www.bizjournals.com/louisville/news/2017/08/10/local-company-gets-60-million-in-financing.html?ana=twt

$38,600,000 Venture capital (Series C)
Xconomy , vcaonline

Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs

Funding Health Science
$21,000,000 Venture capital (Series B)
businesswire

Simplify Medical Closes $21 Million Series B Financing to Support Innovative Cervical Artificial Disc

$30,000,000 Venture capital (Series B)
PE HUB , Xconomy

BioClin Therapeutics inks $30 mln Series B

Messaging Funding Data leaks
$15,000,000 Debt financing
FinSMEs

Unum Therapeutics Receives $15M Credit Facility from Square 1 Bank

Acquisition
GEN

Bio-Rad to Acquire RainDance Technologies Genetic Engineering & Biotechnology News - Biotech from Bench to Business

$45,000,000 Venture capital (Series C)
MassDevice , Geektime

Shockwave Medical raises $45m Series C for Lithoplasty device

$60,000,000 Venture capital
FinSMEs

UK Biotech Company F2G Raises $60M

Funding Health
€46,000,000 Venture capital (Series B)
businesswire , FinSMEs , biospace

Aprea AB: Cancer Company Aprea Closes EUR 46 Million (~USD 51 Million) Series B Financing

$47,100,000 Venture capital (Series D)
FinSMEs

Apellis Pharmaceuticals Completes $47.1M Series D Financing

Health Funding
$32,000,000 Venture capital (Series D)
venturedeal

Apellis Pharma Accepts $32 Million Equity VC

$40,000,000 Venture capital (Series B)
The San Diego Union-Tribune

Effector Therapeutics raises $40 million

Science Health Funding
Xconomy

RainDance Technologies Cancels Long-Awaited IPO

Funding Earnings